These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15964750)

  • 21. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Melatonin and celecoxib improve the outcomes in hamsters with experimental pancreatic cancer.
    Padillo FJ; Ruiz-Rabelo JF; Cruz A; Perea MD; Tasset I; Montilla P; Túnez I; Muntané J
    J Pineal Res; 2010 Oct; 49(3):264-70. PubMed ID: 20626589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Celecoxib and GABA cooperatively prevent the progression of pancreatic cancer in vitro and in xenograft models of stress-free and stress-exposed mice.
    Al-Wadei HA; Al-Wadei MH; Ullah MF; Schuller HM
    PLoS One; 2012; 7(8):e43376. PubMed ID: 22916251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does alpha-linolenic acid in combination with linoleic acid influence liver metastasis and hepatic lipid peroxidation in BOP-induced pancreatic cancer in Syrian hamsters?
    Wenger FA; Kilian M; Jacobi CA; Schimke I; Guski H; Müller JM
    Prostaglandins Leukot Essent Fatty Acids; 2000 Jun; 62(6):329-34. PubMed ID: 10913224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 5-lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophages.
    Rossi A; Pergola C; Koeberle A; Hoffmann M; Dehm F; Bramanti P; Cuzzocrea S; Werz O; Sautebin L
    Br J Pharmacol; 2010 Oct; 161(3):555-70. PubMed ID: 20880396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Simultaneous inhibition of COX-2 and 5-LOX activities augments growth arrest and death of premalignant and malignant human lung cell lines.
    Schroeder CP; Yang P; Newman RA; Lotan R
    J Exp Ther Oncol; 2007; 6(3):183-92. PubMed ID: 17552358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of cyclooxygenase-2 in rat oral cancers and prevention of oral carcinogenesis in rats by selective and nonselective COX inhibitors.
    McCormick DL; Phillips JM; Horn TL; Johnson WD; Steele VE; Lubet RA
    Cancer Prev Res (Phila); 2010 Jan; 3(1):73-81. PubMed ID: 20051374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
    Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
    J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of taurolidine and octreotide on port site and liver metastasis after laparoscopy in an animal model of pancreatic cancer.
    Wenger FA; Kilian M; Braumann C; Neumann A; Ridders J; Peter FJ; Guski H; Jacobi CA
    Clin Exp Metastasis; 2002; 19(2):169-73. PubMed ID: 11964081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eicosanoid metabolism in squamous cell carcinoma cell lines derived from primary and metastatic head and neck cancer and its modulation by celecoxib.
    Schroeder CP; Yang P; Newman RA; Lotan R
    Cancer Biol Ther; 2004 Sep; 3(9):847-52. PubMed ID: 15254428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does enteral nutrition of dietary polyunsaturated fatty acids promote oxidative stress and tumour growth in ductal pancreatic cancer? Experimental trial in Syrian Hamster.
    Gregor JI; Heukamp I; Kilian M; Kiewert C; Schimke I; Kristiansen G; Walz MK; Jacobi CA; Wenger FA
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):67-74. PubMed ID: 16226437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modification of eicosanoid profile in human blood treated by dual COX/LOX inhibitors.
    Pommery J; Pommery N; Hénichart JP
    Prostaglandins Leukot Essent Fatty Acids; 2005 Dec; 73(6):411-7. PubMed ID: 16213697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of celecoxib and the novel anti-cancer agent, dimethylamino-parthenolide, in a developmental model of pancreatic cancer.
    Yip-Schneider MT; Wu H; Njoku V; Ralstin M; Holcomb B; Crooks PA; Neelakantan S; Sweeney CJ; Schmidt CM
    Pancreas; 2008 Oct; 37(3):e45-53. PubMed ID: 18815538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases.
    Attiga FA; Fernandez PM; Weeraratna AT; Manyak MJ; Patierno SR
    Cancer Res; 2000 Aug; 60(16):4629-37. PubMed ID: 10969817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.
    Ye YN; Wu WK; Shin VY; Bruce IC; Wong BC; Cho CH
    Carcinogenesis; 2005 Apr; 26(4):827-34. PubMed ID: 15637091
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The preventive effect of ketoconazole on experimental metastasis from a human pancreatic carcinoma may be related to its effect on prostaglandin synthesis.
    Tzanakakis GN; Krambovitis E; Tsatsakis AM; Vezeridis MP
    Int J Gastrointest Cancer; 2002; 32(1):23-30. PubMed ID: 12630766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Celecoxib, a cyclooxygenase-2 inhibitor, prevents induction of liver preneoplastic lesions in rats.
    Márquez-Rosado L; Trejo-Solís MC; García-Cuéllar CM; Villa-Treviño S
    J Hepatol; 2005 Oct; 43(4):653-60. PubMed ID: 16023763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of celecoxib pharmacodynamics in pancreatic cancer.
    Jimeno A; Amador ML; Kulesza P; Wang X; Rubio-Viqueira B; Zhang X; Chan A; Wheelhouse J; Kuramochi H; Tanaka K; Danenberg K; Messersmith WA; Almuete V; Hruban RH; Maitra A; Yeo CJ; Hidalgo M
    Mol Cancer Ther; 2006 Dec; 5(12):3240-7. PubMed ID: 17172427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
    Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of COX-1 and COX-2 inhibitors on eicosanoid biosynthesis and the release of substance P from the guinea-pig isolated perfused lung.
    Amann R; Schuligoi R; Peskar BA
    Inflamm Res; 2001 Jan; 50(1):50-3. PubMed ID: 11235022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.